Cargando…
Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19
Famotidine is of interest as a possible treatment for COVID-19, with effects on disease-related symptoms and survival reported in observational and retrospective studies, as well as in silico predictions of binding to potential SARS-CoV-2 drug targets. Published studies of famotidine for COVID-19 ha...
Autor principal: | Alper, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786260/ https://www.ncbi.nlm.nih.gov/pubmed/33425958 http://dx.doi.org/10.3389/fmed.2020.614393 |
Ejemplares similares
-
Hepatitis following famotidine: a case report
por: Gupta, Nishant, et al.
Publicado: (2009) -
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series
por: Janowitz, Tobias, et al.
Publicado: (2020) -
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
por: Malone, Robert W., et al.
Publicado: (2020) -
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
por: Malone, Robert W., et al.
Publicado: (2021) -
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients
por: Hogan II, Reed B., et al.
Publicado: (2020)